Delivery Order SPE2DB25D3006-SPE2DB25FXJES
Award Date
5/19/25
Potential Completion Date
5/20/25
Potential Value
$55K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of DEFERASIROX 360 MG TABLET 30S, a pharmaceutical product, and has a firm fixed price of $33,786.47. The contract has an ultimate completion date of May 23, 2025 and was awarded on May 22, 2025. This contract is not designated as a set-aside and was competitively awarded. Amerisourcebergen Drug...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Deferasirox 360 mg tablets, a medication used to treat chronic iron overload conditions. The award has a ceiling value of $16,434.54 and a performance period ending on May 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEFERASIROX 180 MG GRANULE PKT 30S, with a ceiling value of $1,728.00 and a performance period through May 15, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product Deferasirox 500 mg tablets for suspension. The contract has a ceiling value of $2,455.30 and a period of performance through March 21, 2024. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor on this delivery order, which is issued under a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DEFERASIROX 360 MG TABLET 30S. The firm fixed price contract has a potential value of $13,105.98 and a performance completion date of December 29, 2023. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to supply pharmaceuticals, medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,006.27 firm fixed-price contract is for the delivery of Deferiprone 500 mg tablets, a medication used to treat iron overload. The contract is not set aside and represents an order under AmerisourceBergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, with a ceiling value of $34,899.12, is for the provision of Deferiprone 500 mg tablets to support military treatment programs and facilities. The contract is a firm fixed price delivery order with an ultimate completion date of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Deferasirox 500 mg Tablets for Suspension. The contract has a ceiling value of $5,629.92 and an ultimate completion date of September 13, 2024. This is a Firm Fixed Price contract for the delivery of this pharmaceutical product. The award is not associated with any set-aside designation. As one of the largest pharmaceutical distributors in the United States, AmerisourceBergen...
This federal contract award is for the delivery of 50 tablets of the pharmaceutical drug deferiprone, 1,000 mg per tablet, with a 3-times-per-day dosage requirement. The contract, valued at $13,040.76, was awarded to Amerisourcebergen Drug Corp, Corporate Office Division, by the Defense Logistics Agency (DLA) Troop Support Medical. The award is a delivery order under the DLA's Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which provides a comprehensive range...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $16,553.85, is for the medical product Injectafer 750 mg/15 ml vial. The contract has a firm fixed price pricing type and a period of performance through May 23, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...